Label Update: FDA Green Lights Dupilumab for AD Patients With Moderate-to-Severe Hand and Foot Involvement

The U.S. Food and Drug Administration (FDA) has updated the label for dupilumab (Dupixent, Regeneron Pharmaceuticals, Inc. and Sanofi), adding efficacy and safety data for people aged 12 years and older with atopic dermatitis (AD) and uncontrolled moderate-to-severe hand and/or foot involvement.  More than twice as many atopic dermatitis patients with uncontrolled moderate-to-severe hand and/or foot […]

Advances in Wound Healing for Dermatologists

Robert S. Kirsner, MD, PhD, chairman and Harvey Blank professor in the Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery at the University of Miami Miller School of Medicine in Miami, FL, shares tips on how dermatologists can improve wound healing including with scarless skin grafting, aspirin, or the bacteria found in yogurt.

Exploring Microbiome Changes in Lichen Striatus Hypopigmentation: New Insights May Mean New Treatment Options

Cutibacterium acnes significantly influences the bacterial community in hypopigmented Lichen striatus (LS), new research shows. For the study, researchers from Korea led by Associate Professor Yun Hak Kim from the Department of Anatomy and the Department of Biomedical Informatics and Professor Hyun-Chang Go from the Department of Dermatology, both at Pusan National University, analyzed skin samples of […]